On the other hand, the anti-Scl-70 antibody titers showed a trend of BLM dose-dependent increase, which was significantly higher in the high-dose BLM group, but not statistically different in the low- and medium-dose BLM groups compared with the control group ( Figure 4B ). 3.5.
1
—
—